Skip to main navigation Skip to search Skip to main content

A Randomized, Double-Blind, Placebo-controlled, Study Investigating Vaccine Responses in Adults with Moderate to Severe Atopic Dermatitis Treated with Dupilumab

Project: Research

Project Details

StatusFinished
Effective start/end date12/3/14 → 08/2/16

Funding

  • Regeneron Pharmaceuticals Incorporated: $28,375.61